| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3976624 | Brachytherapy | 2014 | 8 Pages |
Abstract
A “short” course HDR-ISBT is effective, safe, and convenient with acceptable local control and toxicity. Higher dose per fraction is similar to an external beam radiotherapy stereotactic boost with the inherent advantages of brachytherapy. A shorter overall time for HDR-ISBT means less time that patients are immobilized and in hospital, making it less resource intensive than a longer course.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
David D'Souza, Ericka Wiebe, Nikhilesh Patil, Akira Sugimoto, Michel Prefontaine, Simran Aulakh, Frances Whiston, Larry Stitt, Kathleen Surry,